<?xml version="1.0" encoding="UTF-8"?>
<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#"> 
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> 
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes"/>
  <meta name="type" content="article"/>
  <meta name="category" content="article"/>
  <meta name="HW.identifier" content="/biorxiv/early/2020/04/01/2020.03.31.017657.atom"/>
  <meta name="HW.pisa" content="biorxiv;2020.03.31.017657v1"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Molecular Docking Analysis of Some Phytochemicals on Two Sars-Cov-2 Targets"/>
  <meta name="DC.Identifier" content="10.1101/2020.03.31.017657"/>
  <meta name="DC.Date" content="2020-04-01"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="DC.Rights" content="© 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/"/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (previously called 2019 novel coronavirus (2019-nCoV) is the causative agent of coronavirus disease 2019 (COVID-19), a disease recently declared a global public health emergency by the World Health Organization. At the moment there is no available drug(s) and vaccine(s) for the treatment or prevention of COVID-19. SARS-CoV-2 spike envelope glycoprotein (S) and main protease (Mpro) are crucial determinants in the virus infectious process and have been recognized as key targets for therapeutics designs. In the present in silico study, a library of 22 phytochemicals with antiviral activity obtained from PubChem Database was screened for activity against 6lu7 and 6vsb with the PyRX software. Six lead compounds with binding energies within the range of −9 to −9.6 Kcal/mol were selected for molecular docking analyses against 6lu7. SwissADMET and Molinspiration Cheminformatics for CLogP (mean range of 0.77-8.72) of the lead compounds showed no correlation observed between lipophilicity and interaction with receptors and all the compounds except for baicalin exhibited drug-like properties based on Lipinski and Veber filter. The ADMET profile showed that lead compounds lack hepatotoxicity and mutagenicity effects while they show variable immunotoxicity, carcinogenicity and cytotoxicity. The compounds Scopodulic acid and Dammarenolic acid showed the best-fit value of activity against SARS-CoV-2 spike glycoprotein 6vsb and main protease Mpro 6lu7 targets, respectively. Our data suggest silibinin a repurposing candidate drug may have multitarget activity against SARS-CoV-2. So further in vitro and in vivo evaluations are recommended."/>
  <meta name="DC.Contributor" content="Amaka Ubani"/>
  <meta name="DC.Contributor" content="Francis Agwom"/>
  <meta name="DC.Contributor" content="Nathan Yakubu Shehu"/>
  <meta name="DC.Contributor" content="Pam Luka"/>
  <meta name="DC.Contributor" content="Arinze Umera"/>
  <meta name="DC.Contributor" content="Uzal Umar"/>
  <meta name="DC.Contributor" content="Simeon Omale"/>
  <meta name="DC.Contributor" content="Nnaemeka Emmanuel Nnadi"/>
  <meta name="DC.Contributor" content="John Chinyere Aguiyi"/>
  <meta name="article:published_time" content="2020-04-01"/>
  <meta name="article:section" content="New Results"/>
  <meta name="citation_title" content="Molecular Docking Analysis of Some Phytochemicals on Two Sars-Cov-2 Targets"/>
  <meta name="citation_abstract" lang="en" content="&lt;;p&gt;;Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (previously called 2019 novel coronavirus (2019-nCoV) is the causative agent of coronavirus disease 2019 (COVID-19), a disease recently declared a global public health emergency by the World Health Organization. At the moment there is no available drug(s) and vaccine(s) for the treatment or prevention of COVID-19. SARS-CoV-2 spike envelope glycoprotein (S) and main protease (Mpro) are crucial determinants in the virus infectious process and have been recognized as key targets for therapeutics designs. In the present in silico study, a library of 22 phytochemicals with antiviral activity obtained from PubChem Database was screened for activity against 6lu7 and 6vsb with the PyRX software. Six lead compounds with binding energies within the range of -9 to -9.6 Kcal/mol were selected for molecular docking analyses against 6lu7. SwissADMET and Molinspiration Cheminformatics for CLogP (mean range of 0.77-8.72) of the lead compounds showed no correlation observed between lipophilicity and interaction with receptors and all the compounds except for baicalin exhibited drug-like properties based on Lipinski and Veber filter. The ADMET profile showed that lead compounds lack hepatotoxicity and mutagenicity effects while they show variable immunotoxicity, carcinogenicity and cytotoxicity. The compounds Scopodulic acid and Dammarenolic acid showed the best-fit value of activity against SARS-CoV-2 spike glycoprotein 6vsb and main protease Mpro 6lu7 targets, respectively. Our data suggest silibinin a repurposing candidate drug may have multitarget activity against SARS-CoV-2. So further in vitro and in vivo evaluations are recommended.&lt;;/p&gt;;"/>
  <meta name="citation_journal_title" content="bioRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="citation_publication_date" content="2020/01/01"/>
  <meta name="citation_mjid" content="biorxiv;2020.03.31.017657v1"/>
  <meta name="citation_id" content="2020.03.31.017657v1"/>
  <meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.03.31.017657v1"/>
  <meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.31.017657v1.abstract"/>
  <meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.31.017657v1.full"/>
  <meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.03.31.017657"/>
  <meta name="citation_num_pages" content="14"/>
  <meta name="citation_article_type" content="Article"/>
  <meta name="citation_section" content="New Results"/>
  <meta name="citation_firstpage" content="2020.03.31.017657"/>
  <meta name="citation_author" content="Amaka Ubani"/>
  <meta name="citation_author_institution" content="Department of Pharmaceutical &amp;; Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Jos"/>
  <meta name="citation_author_email" content="agwom2020@gmail.com"/>
  <meta name="citation_author" content="Francis Agwom"/>
  <meta name="citation_author_institution" content="Department of Pharmaceutical &amp;; Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Jos"/>
  <meta name="citation_author_email" content="agwom2020@gmail.com"/>
  <meta name="citation_author" content="Nathan Yakubu Shehu"/>
  <meta name="citation_author_institution" content="Department of Pharmaceutical &amp;; Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Jos"/>
  <meta name="citation_author_institution" content="Department of Medicine, Jos University Teaching Hospital"/>
  <meta name="citation_author_email" content="agwom2020@gmail.com"/>
  <meta name="citation_author_email" content="nyshehu25@gmail.com"/>
  <meta name="citation_author" content="Pam Luka"/>
  <meta name="citation_author_institution" content="Biotechnology Centre, National Veterinary Research Institute"/>
  <meta name="citation_author_email" content="pamluka08@gmail.com"/>
  <meta name="citation_author" content="Arinze Umera"/>
  <meta name="citation_author_institution" content="African Centre of Excellence in Phytomedicine Research and development (ACEPRD), University of Jos"/>
  <meta name="citation_author_email" content="jca757@yahoo.com"/>
  <meta name="citation_author" content="Uzal Umar"/>
  <meta name="citation_author_institution" content="African Centre of Excellence in Phytomedicine Research and development (ACEPRD), University of Jos"/>
  <meta name="citation_author_email" content="jca757@yahoo.com"/>
  <meta name="citation_author" content="Simeon Omale"/>
  <meta name="citation_author_institution" content="African Centre of Excellence in Phytomedicine Research and development (ACEPRD), University of Jos"/>
  <meta name="citation_author_email" content="jca757@yahoo.com"/>
  <meta name="citation_author" content="Nnaemeka Emmanuel Nnadi"/>
  <meta name="citation_author_institution" content="Department of Microbiology, Faculty of Natural and Applied Sciences, Plateau State University"/>
  <meta name="citation_author_email" content="eennadi@gmail.com"/>
  <meta name="citation_author" content="John Chinyere Aguiyi"/>
  <meta name="citation_author_email" content="eennadi@gmail.com"/>
  <meta name="citation_author_email" content="jca757@yahoo.com"/>
  <meta name="citation_reference" content="Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. 2020:1–4."/>
  <meta name="citation_reference" content="Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt H-R, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. 2003;348(20):1967–76."/>
  <meta name="citation_reference" content="Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler DJC. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. 2020."/>
  <meta name="citation_reference" content="Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RAJNEJoM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. 2012;367(19):1814–20."/>
  <meta name="citation_reference" content="Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert JJSMW. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. 2020;150(1112)."/>
  <meta name="citation_reference" content="Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld RJS. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. 2003;300(5626):1763–7."/>
  <meta name="citation_reference" content="Hilgenfeld RJTFj. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. 2014;281(18):4085–96."/>
  <meta name="citation_reference" content="Ferenci P, Scherzer TM, Kerschner H, Rutter K, Beinhardt S, Hofer H, et al. Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. 2008;135(5):1561–7."/>
  <meta name="citation_reference" content="Chen L, Li J, Luo C, Liu H, Xu W, Chen G, et al. Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features. 2006;14(24):8295–306."/>
  <meta name="citation_reference" content="Ginzberg I, Tokuhisa JG, Veilleux REJPR. Potato steroidal glycoalkaloids: biosynthesis and genetic manipulation. 2009;52(1):1–15."/>
  <meta name="citation_reference" content="Friedman M, McDonald GM, Filadelfi-Keszi MJCRiPS. Potato glycoalkaloids: chemistry, analysis, safety, and plant physiology. 1997;16(1):55–132."/>
  <meta name="citation_reference" content="Thorne H, Clarke G, Skuce RJAr. The inactivation of herpes simplex virus by some Solanaceae glycoalkaloids. 1985;5(6):335–43."/>
  <meta name="citation_reference" content="Banerjee P, Eckert AO, Schrey AK, Preissner RJNar. ProTox-II: a webserver for the prediction of toxicity of chemicals. 2018;46(W1):W257–W63."/>
  <meta name="citation_reference" content="Esimone CO, Eck G, Nworu CS, Hoffmann D, Überla K, Proksch PJP. Dammarenolic acid, a secodammarane triterpenoid from Aglaia sp. shows potent anti-retroviral activity in vitro. 2010;17(7):540–7."/>
  <meta name="citation_reference" content="Esimone C, Eck G, Duong T, Überla K, Proksch P, Grunwald TJDP-AIJoPS. Potential anti-respiratory syncytial virus lead compounds from Aglaia species. 2008;63(10):768–73."/>
  <meta name="citation_reference" content="Liu C-H, Jassey A, Hsu H-Y, Lin L-TJM. Antiviral Activities of Silymarin and Derivatives. 2019;24(8):1552."/>
  <meta name="citation_reference" content="Polyak SJ, Ferenci P, Pawlotsky JMJH. Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. 2013;57(3):1262–71."/>
  <meta name="citation_reference" content="Wagoner J, Negash A, Kane OJ, Martinez LE, Nahmias Y, Bourne N, et al. Multiple effects of silymarin on the hepatitis C virus lifecycle. 2010;51(6):1912–21."/>
  <meta name="citation_reference" content="Biovia DSJSD. Discovery Studio Modeling Environment Release 2017, Dassault Systemes. 2016."/>
  <meta name="citation_reference" content="Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Chemical biology: Springer; 2015.p. 243–50."/>
  <meta name="citation_reference" content="Daina A, Michielin O, Zoete VJSr. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. 2017;7:42717."/>
  <meta name="citation_reference" content="Jarrahpour A, Motamedifar M, Zarei M, Youssoufi M, Mimouni M, Chohan Z, et al. Petra, osiris, and molinspiration together as a guide in drug design: predictions and correlation structure/antibacterial activity relationships of new N-Sulfonyl monocyclic β-lactams. 2010;185(2):491–7."/>
  <meta name="citation_reference" content="Drwal MN, Banerjee P, Dunkel M, Wettig MR, Preissner RJNar. ProTox: a web server for the in silico prediction of rodent oral toxicity. 2014;42(W1):W53–W8."/>
  <meta name="twitter:title" content="Molecular Docking Analysis of Some Phytochemicals on Two Sars-Cov-2 Targets"/>
  <meta name="twitter:site" content="@biorxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="twitter:description" content="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (previously called 2019 novel coronavirus (2019-nCoV) is the causative agent of coronavirus disease 2019 (COVID-19), a disease recently declared a global public health emergency by the World Health Organization. At the moment there is no available drug(s) and vaccine(s) for the treatment or prevention of COVID-19. SARS-CoV-2 spike envelope glycoprotein (S) and main protease (Mpro) are crucial determinants in the virus infectious process and have been recognized as key targets for therapeutics designs. In the present in silico study, a library of 22 phytochemicals with antiviral activity obtained from PubChem Database was screened for activity against 6lu7 and 6vsb with the PyRX software. Six lead compounds with binding energies within the range of −9 to −9.6 Kcal/mol were selected for molecular docking analyses against 6lu7. SwissADMET and Molinspiration Cheminformatics for CLogP (mean range of 0.77-8.72) of the lead compounds showed no correlation observed between lipophilicity and interaction with receptors and all the compounds except for baicalin exhibited drug-like properties based on Lipinski and Veber filter. The ADMET profile showed that lead compounds lack hepatotoxicity and mutagenicity effects while they show variable immunotoxicity, carcinogenicity and cytotoxicity. The compounds Scopodulic acid and Dammarenolic acid showed the best-fit value of activity against SARS-CoV-2 spike glycoprotein 6vsb and main protease Mpro 6lu7 targets, respectively. Our data suggest silibinin a repurposing candidate drug may have multitarget activity against SARS-CoV-2. So further in vitro and in vivo evaluations are recommended."/>
  <meta name="og-title" property="og:title" content="Molecular Docking Analysis of Some Phytochemicals on Two Sars-Cov-2 Targets"/>
  <meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.03.31.017657v1"/>
  <meta name="og-site-name" property="og:site_name" content="bioRxiv"/>
  <meta name="og-description" property="og:description" content="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (previously called 2019 novel coronavirus (2019-nCoV) is the causative agent of coronavirus disease 2019 (COVID-19), a disease recently declared a global public health emergency by the World Health Organization. At the moment there is no available drug(s) and vaccine(s) for the treatment or prevention of COVID-19. SARS-CoV-2 spike envelope glycoprotein (S) and main protease (Mpro) are crucial determinants in the virus infectious process and have been recognized as key targets for therapeutics designs. In the present in silico study, a library of 22 phytochemicals with antiviral activity obtained from PubChem Database was screened for activity against 6lu7 and 6vsb with the PyRX software. Six lead compounds with binding energies within the range of −9 to −9.6 Kcal/mol were selected for molecular docking analyses against 6lu7. SwissADMET and Molinspiration Cheminformatics for CLogP (mean range of 0.77-8.72) of the lead compounds showed no correlation observed between lipophilicity and interaction with receptors and all the compounds except for baicalin exhibited drug-like properties based on Lipinski and Veber filter. The ADMET profile showed that lead compounds lack hepatotoxicity and mutagenicity effects while they show variable immunotoxicity, carcinogenicity and cytotoxicity. The compounds Scopodulic acid and Dammarenolic acid showed the best-fit value of activity against SARS-CoV-2 spike glycoprotein 6vsb and main protease Mpro 6lu7 targets, respectively. Our data suggest silibinin a repurposing candidate drug may have multitarget activity against SARS-CoV-2. So further in vitro and in vivo evaluations are recommended."/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="citation_date" content="2020-04-01"/> 
  <meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/> 
  <title>Molecular Docking Analysis of Some Phytochemicals on Two Sars-Cov-2 Targets | bioRxiv</title> 
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-1219985 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results"> 
  <div class="article fulltext-view ">
   <span class="highwire-journal-article-marker-start"/>
   <div class="section abstract" id="abstract-1">
    <h2 class="">Abstract</h2>
    <p id="p-2">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (previously called 2019 novel coronavirus (2019-nCoV) is the causative agent of coronavirus disease 2019 (COVID-19), a disease recently declared a global public health emergency by the World Health Organization. At the moment there is no available drug(s) and vaccine(s) for the treatment or prevention of COVID-19. SARS-CoV-2 spike envelope glycoprotein (S) and main protease (M
     <sup>pro</sup>) are crucial determinants in the virus infectious process and have been recognized as key targets for therapeutics designs. In the present 
     <em>in silico</em> study, a library of 22 phytochemicals with antiviral activity obtained from PubChem Database was screened for activity against 6lu7 and 6vsb with the PyRX software. Six lead compounds with binding energies within the range of −9 to −9.6 Kcal/mol were selected for molecular docking analyses against 6lu7. SwissADMET and Molinspiration Cheminformatics for CLogP (mean range of 0.77-8.72) of the lead compounds showed no correlation observed between lipophilicity and interaction with receptors and all the compounds except for baicalin exhibited drug-like properties based on Lipinski and Veber filter. The ADMET profile showed that lead compounds lack hepatotoxicity and mutagenicity effects while they show variable immunotoxicity, carcinogenicity and cytotoxicity. The compounds Scopodulic acid and Dammarenolic acid showed the best-fit value of activity against SARS-CoV-2 spike glycoprotein 6vsb and main protease M
     <sup>pro</sup> 6lu7 targets, respectively. Our data suggest silibinin a repurposing candidate drug may have multitarget activity against SARS-CoV-2. So further in vitro and in vivo evaluations are recommended.
    </p>
   </div>
   <div class="section" id="sec-1">
    <h2 class="">1. Introduction</h2>
    <p id="p-3">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), family 
     <em>Coronaviridae</em>, genus 
     <em>Betacoronavirus</em>, is spreading widely in China, causing coronavirus disease 2019 (COVID-19)(
     <a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>). Since 2003, three Coronaviruses have been associated with pneumonia, the first was severe acute respiratory syndrome coronavirus (SARS-CoV)(
     <a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>) which affected 8,098 people causing 774 deaths between 2002 and 2003(
     <a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>), the second was Middle-East respiratory syndrome coronavirus (MERS-CoV)(
     <a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>) which affected 27 countries and infecting a total of 2,494 individuals and claiming 858 lives(
     <a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>). SARS-CoV-2 is a human pathogen which has been declared a global pandemic by the World Health Organisation (
     <a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>). SARS-CoV and SARS-CoV-2 are closely related and originated in bats, who most likely serve as a reservoir host for these two viruses (
     <a id="xref-ref-4-3" class="xref-bibr" href="#ref-4">4</a>). To date, no therapeutics or vaccines are approved against any human-infecting coronaviruses(
     <a id="xref-ref-4-4" class="xref-bibr" href="#ref-4">4</a>).
    </p>
    <p id="p-4">The entry into the host cell by the Coronaviruses is usually mediated by spike (S) glycoprotein (
     <a id="xref-ref-4-5" class="xref-bibr" href="#ref-4">4</a>). This glycoprotein interacts with the angiotensin-converting enzyme 2 (ACE2) enabling the virus penetration into the host. The main protease (M
     <sup>pro</sup> also known as 3CL
     <sup>pro</sup>) is one of the best-characterized drug targets among coronaviruses (
     <a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>). The protease enzyme is essential for processing the polyproteins that are translated from the viral RNA(
     <a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>). For this study, these two drug targets were selected for SARS-CoV-2 using plant-based compounds screened against them.
    </p>
    <p id="p-5">Therefore, potent inhibitors of these two targets will be able to interfere with the SARS COV-2 replication process and thus serves as potential drugs for the management of the COVID-19. Hence, this work is aimed at identifying other potential lead compounds of plant origin that can serve as candidates for testing against the SARS COV2 virus.</p>
   </div>
   <div class="section" id="sec-2">
    <h2 class="">2. Results</h2>
    <p id="p-6">A library of 22 compounds of plant origin known to have antiviral activity was obtained from Pubchem database. Though the compounds are chemically diverse they consist of largely flavonoids and terpenes. Some compounds from the citrus family made were found among the library and demonstrated some good binding affinities.</p>
    <p id="p-7">Most of the compounds have shown similar binding affinities to the selected protein targets (6lu7 and 6vsb) compared to the training sets of known ligands to the selected targets. (See 
     <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">table 1</a>)
    </p>
    <div id="T1" class="table pos-float">
     <div class="table-inline table-callout-links">
      <div class="callout">
       <span>View this table:</span>
       <ul class="callout-links">
        <li class="view-inline first">
         <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1231334/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a>
        </li>
        <li class="view-popup">
         <a href="/highwire/markup/1231334/expansion?width=1000&amp;;height=500&amp;;iframe=true&amp;;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a>
        </li>
        <li class="download-ppt last">
         <a href="/highwire/powerpoint/1231334" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a>
        </li>
       </ul>
      </div>
     </div>
     <div class="table-caption">
      <span class="table-label">Table 1.</span>
      <p id="p-8" class="first-child">Comparison of Binding affinities to some known ligands and the co-crystalised ligand</p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <p id="p-9">However, the top six compounds with most favourable binding affinity were selected for each of the targets.</p>
    <p id="p-10">The outcome of the binding affinities of the selected compounds on the 6lu7 and 6vbs targets are presented in 
     <strong>
      <a id="xref-table-wrap-2-1" class="xref-table" href="#T2">Table 2</a> and 
      <a id="xref-table-wrap-3-1" class="xref-table" href="#T3">Table 3</a>
     </strong> respectively.
    </p>
    <div id="T2" class="table pos-float">
     <div class="table-inline table-callout-links">
      <div class="callout">
       <span>View this table:</span>
       <ul class="callout-links">
        <li class="view-inline first">
         <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1231331/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a>
        </li>
        <li class="view-popup">
         <a href="/highwire/markup/1231331/expansion?width=1000&amp;;height=500&amp;;iframe=true&amp;;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a>
        </li>
        <li class="download-ppt last">
         <a href="/highwire/powerpoint/1231331" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a>
        </li>
       </ul>
      </div>
     </div>
     <div class="table-caption">
      <span class="table-label">TABLE 2</span>
      <p id="p-11" class="first-child">Binding affinities of the compounds on the 6vsb and their Interaction with the binding site</p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <div id="T3" class="table pos-float">
     <div class="table-inline table-callout-links">
      <div class="callout">
       <span>View this table:</span>
       <ul class="callout-links">
        <li class="view-inline first">
         <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1231327/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a>
        </li>
        <li class="view-popup last">
         <a href="/highwire/markup/1231327/expansion?width=1000&amp;;height=500&amp;;iframe=true&amp;;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a>
        </li>
       </ul>
      </div>
     </div>
     <div class="table-caption">
      <span class="table-label">TABLE 3</span>
      <p id="p-12" class="first-child">Binding affinities of the compounds on the 6lu7</p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <p id="p-13">The binding affinities of the top six compounds on the 6vsb target are comparable to each other that is they all lie within a close range of 9 to 9.6 kcal/mol indicating that they might likely have equal or comparable potential as lead compounds for the 6vsb spike glycoprotein.</p>
    <p id="p-14">One of the compounds sylibinin (
     <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>)is an FDA approved drug, which showed up as active on both M
     <sup>Pro</sup> and spike glycoprotein will make a good candidate of repurposing. Finding Quercetin as a potential inhibitor of the Mp
     <sup>ro</sup> Protein (6flu7) of the SARS-COV-2 corresponds with an earlier report(
     <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>)
    </p>
    <p id="p-15">Looking at the cLog P of the compounds, there was no correlation observed between the lipophilicity and the interaction with the receptors. However, for the compounds acting on 6lu7 (S/N 3,4,7,8,9 and 10 in 
     <a id="xref-table-wrap-4-1" class="xref-table" href="#T4">Table 4</a>), interaction with the receptor is correlated with low lipophilicity except for solanidine and Dammarenolic acid that have high cLogP values. Though both compounds also use their polar functional groups in interacting with the receptor. Bacailin and Naringenin showed good hydrogen bond interaction with the 6vsb receptor due to their polarity.
    </p>
    <div id="T4" class="table pos-float">
     <div class="table-inline table-callout-links">
      <div class="callout">
       <span>View this table:</span>
       <ul class="callout-links">
        <li class="view-inline first">
         <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1231330/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a>
        </li>
        <li class="view-popup last">
         <a href="/highwire/markup/1231330/expansion?width=1000&amp;;height=500&amp;;iframe=true&amp;;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a>
        </li>
       </ul>
      </div>
     </div>
     <div class="table-caption">
      <span class="table-label">Table 4.</span>
      <p id="p-16" class="first-child">Comparison of the calculated cLog P values for the selected compounds</p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <p id="p-17">Filtering the compounds for drug-likeness based on Linpinski’s and/or Veber’s rule showed that all the compounds have a drug like properties except baicalin which failed the two filtering scales applied (
     <a id="xref-table-wrap-5-1" class="xref-table" href="#T5">Table 5</a>). This implies that baicalin is not worth considering further without any structural modification.
    </p>
    <div id="T5" class="table pos-float">
     <div class="table-inline table-callout-links">
      <div class="callout">
       <span>View this table:</span>
       <ul class="callout-links">
        <li class="view-inline first">
         <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1231328/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a>
        </li>
        <li class="view-popup">
         <a href="/highwire/markup/1231328/expansion?width=1000&amp;;height=500&amp;;iframe=true&amp;;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a>
        </li>
        <li class="download-ppt last">
         <a href="/highwire/powerpoint/1231328" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a>
        </li>
       </ul>
      </div>
     </div>
     <div class="table-caption">
      <span class="table-label">Table 5.</span>
      <span class="caption-title">Drug likeness</span>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <div id="T6" class="table pos-float">
     <div class="table-inline table-callout-links">
      <div class="callout">
       <span>View this table:</span>
       <ul class="callout-links">
        <li class="view-inline first">
         <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1231329/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a>
        </li>
        <li class="view-popup">
         <a href="/highwire/markup/1231329/expansion?width=1000&amp;;height=500&amp;;iframe=true&amp;;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a>
        </li>
        <li class="download-ppt last">
         <a href="/highwire/powerpoint/1231329" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a>
        </li>
       </ul>
      </div>
     </div>
     <div class="table-caption">
      <span class="table-label">Table 6.</span>
      <p id="p-18" class="first-child">Predicted Toxicity Profile of the compounds using PROTOX II</p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <div id="F1" class="fig pos-float type-figure odd">
     <div class="highwire-figure">
      <div class="fig-inline-img-wrapper">
       <div class="fig-inline-img">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F1.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="(a) Dammarenolic acid in the binding pocket of 6lu7 (b) Binding interactions between dammarenolic acid and the 6lu7 protein" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1754520326" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;(a) Dammarenolic acid in the binding pocket of 6lu7 (b) Binding interactions between dammarenolic acid and the 6lu7 protein&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
         <span class="hw-responsive-img">
          <img class="highwire-fragment fragment-image lazyload" alt="Figure 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F1.medium.gif" width="440" height="153"/>
          <noscript>
           <img class="highwire-fragment fragment-image" alt="Figure 1." src="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F1.medium.gif" width="440" height="153"/>
          </noscript>
         </span>
        </a>
       </div>
      </div>
      <ul class="highwire-figure-links inline">
       <li class="download-fig first">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1." data-icon-position="" data-hide-link-title="0">Download figure</a>
       </li>
       <li class="new-tab last">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
       </li>
      </ul>
     </div>
     <div class="fig-caption">
      <span class="fig-label">Figure 1.</span>
      <p id="p-19" class="first-child">(a) Dammarenolic acid in the binding pocket of 6lu7 (b) Binding interactions between dammarenolic acid and the 6lu7 protein</p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <div id="F2" class="fig pos-float type-figure odd">
     <div class="highwire-figure">
      <div class="fig-inline-img-wrapper">
       <div class="fig-inline-img">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F2.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="2D interaction of 6VSB with Silibinin" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1754520326" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;2D interaction of 6VSB with Silibinin&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
         <span class="hw-responsive-img">
          <img class="highwire-fragment fragment-image lazyload" alt="Figure 2:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F2.medium.gif" width="440" height="369"/>
          <noscript>
           <img class="highwire-fragment fragment-image" alt="Figure 2:" src="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F2.medium.gif" width="440" height="369"/>
          </noscript>
         </span>
        </a>
       </div>
      </div>
      <ul class="highwire-figure-links inline">
       <li class="download-fig first">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2:" data-icon-position="" data-hide-link-title="0">Download figure</a>
       </li>
       <li class="new-tab last">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/04/01/2020.03.31.017657/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
       </li>
      </ul>
     </div>
     <div class="fig-caption">
      <span class="fig-label">Figure 2:</span>
      <p id="p-20" class="first-child">2D interaction of 6VSB with Silibinin</p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <p id="p-21">The predicted toxicity profile of the selected compounds shows that all the compounds are likely to be relatively safe. Which makes them good potential candidates for anti-infectives because the chances of achieving selective toxicity are high. Baicalin is most likely the safest.</p>
   </div>
   <div class="section" id="sec-3">
    <h2 class="">Discussion</h2>
    <p id="p-22">Two compounds among the top six selected for each target, solanidine and sylibinin were observed to have a good binding affinity on both the 6vsb and the 6flu7. This makes them potential multitarget acting inhibitors on the SARS-COV2. Solanidine is a Steroidal glycoalkaloids found in potatoes(
     <a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>), although toxic to humans and animals, Solanidine has been reported to be effective against herpes viruses (HSV), herpes genitalis and herpes zoster(
     <a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>) Its activity against HSV is attributed to the presence of a sugar moiety(
     <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>). In silico method of drug screening using PROTOX II, showed that Solanidine is cytotoxic and immunotoxic. Prototox II is a cost and time conservative approach of testing and determining the toxicity of a compound to be considered a drug of choice(
     <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>). It incorporates molecular similarity, pharmacophores, fragment propensities and machine-learning models for the prediction of various toxicity endpoints; such as acute toxicity, hepatotoxicity, cytotoxicity, carcinogenicity, mutagenicity, immunotoxicity, adverse outcomes pathways (Tox21) and toxicity targets(
     <a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a>)
    </p>
    <p id="p-23">A safe drug must not be toxic to its host target. Based on the Protox II evaluation of Toxicity, Dammarenolic acid emerges as the compound of choice with the least toxicity. Dammarenolic acid has been reported as effective antiviral agents Dammarenolic acid potently inhibited the in vitro replication of other retroviruses, including simian immunodeficiency virus and Murine leukaemic virus in vector-based antiviral screening studies and has been proposed as a potential lead compound in the development of antiretrovirals. (
     <a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>) The compound is cytotoxic and demonstrates potential against the respiratory syncytial virus(
     <a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>). We therefore propose that the evaluation of Dammarenolic acid will hold the key to COVID19 drug considering its drugability and low toxicity.
    </p>
    <p id="p-24">This study proposes a potential re-purposing of silybinin for the management of COVID19 diseases. Silybinin(Silymarin) possesses potent antiviral activities against numerous viruses, particularly hepatitis C virus (HCV)(
     <a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>, 
     <a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>) It has been reported to have activities against a wide range of viral groups including flaviviruses (hepatitis C virus and dengue virus), togaviruses (Chikungunya virus and Mayaro virus), influenza virus, human immunodeficiency virus, and hepatitis B virus(
     <a id="xref-ref-16-2" class="xref-bibr" href="#ref-16">16</a>). Silymarin inhibits HCV in both 
     <em>in vitro</em> and 
     <em>in vivo</em> by inhibiting HCV entry, RNA synthesis, viral protein expression and infectious virus production; in addition, it also acts by blocking off the virus cell-to-cell spread(
     <a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>). As an FDA approved drug for the management of Hepatitis disease. In silico analysis of this drugs in this study has shown that it has activity against SAR COV 2 S-glycoprotein and proteas(M
     <sup>pro</sup>) targets making it a drug to be considered with multi-target ability in the management of this disease.
    </p>
   </div>
   <div class="section" id="sec-4">
    <h2 class="">4. Materials and Methods</h2>
    <p id="p-25">Plant Compounds with antiviral activities were mined from the PubChem database (
     <a href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</a>). Two proteins including the main protease (6lu7) and the crystal structure of COVID-19 main protease(
     <a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>) in complex with an inhibitor N3 and the Spike glycoprotein, N-ACETYL-D-GLUCOSAMINE (6vsb10.1126/science.abb2507) were downloaded from the protein database (PDB). The proteins were prepared using Discovery studio (version)(
     <a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>) and a rigid docking scoring function was carried out using PyRx software(
     <a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>). The results of the dock poses were visualized using Discovery Studio.
    </p>
    <p id="p-26">The Physicochemical Properties and druggability of selected compounds were predicted using SwissADME(
     <a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>) and Molinspiration(
     <a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>) platforms and their predicted toxicity profile also compared using the PROTOX platform(
     <a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>)
    </p>
   </div>
   <div class="section" id="sec-5">
    <h2 class="">5. Conclusions</h2>
    <p id="p-27">From the 22 phyto-compounds that were virtually screened, Scopodulcic acid and Dammarenolic acid showed the best binding energies with the Spike glycoprotein (6vsb) and the M
     <sup>pro</sup> (6flu7) respectively. This makes them potential lead compounds for development into candidates against the SARS-COV-2. Furthermore, the FDA approved drug silybinin (Legalon) with good binding affinity on the two targets can be evaluated further for possible repurposing against the SARS-COV-2 virus. We, therefore, propose that these lead compounds be tried for the COVID19 disease management
    </p>
   </div>
   <div class="section" id="sec-6">
    <h2 class="">Author Contributions</h2>
    <p id="p-28">For research articles with several authors, a short paragraph specifying their individual contributions must be provided. The following statements should be used “Conceptualization, N.E. A.U and F.A; methodology, A.U,F.A; software, A.U,F.A; validation N.E. A.U, N.S., S.O,J.C..A, A.U,U.U,L.P,and Z.Z formal analysis, X.X.; investigation, X.X.; resources, X.X.; data curation, F.A,A.U; writing—original draft preparation, N.E. A.U, N.S., S.O,J.C..A, A.U,U.U,L.P,and; writing—review and editing, N.E. A.U, N.S., S.O,J.C..A, A.U,U.U,L.P,and; visualization, X.X.; supervision, J.CA,N.E;; funding acquisition, J.C.A All authors have read and agreed to the published version of the manuscript.”, please turn to the CRediT taxonomy for the term explanation. Authorship must be limited to those who have contributed substantially to the work reported.</p>
   </div>
   <div class="section" id="sec-7">
    <h2 class="">Funding</h2>
    <p id="p-29">This research was funded by World bank-IDA, grant number ACE-126974” given to J.C.A.</p>
   </div>
   <div class="section COI-statement" id="sec-8">
    <h2 class="">Conflicts of Interest</h2>
    <p id="p-30">Declare conflicts of interest or state “The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results”.</p>
   </div>
   <div class="section ref-list" id="ref-list-1">
    <h2 class="">References</h2>
    <ol class="cit-list ref-use-labels">
     <li>
      <span class="ref-label">1.</span>
      <a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.1">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Zhou</span>
          <span class="cit-name-given-names">P</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Yang</span>
          <span class="cit-name-given-names">X-L</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Wang</span>
          <span class="cit-name-given-names">X-G</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hu</span>
          <span class="cit-name-given-names">B</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Zhang</span>
          <span class="cit-name-given-names">L</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Zhang</span>
          <span class="cit-name-given-names">W</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <abbr class="cit-jnl-abbrev">A pneumonia outbreak associated with a new coronavirus of probable bat origin</abbr>. 
         <span class="cit-pub-date">2020</span>:
         <span class="cit-fpage">1</span>–
         <span class="cit-lpage">4</span>.
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <span class="ref-label">2.</span>
      <a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text" id="ref-2">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.2">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Drosten</span>
          <span class="cit-name-given-names">C</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Günther</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Preiser</span>
          <span class="cit-name-given-names">W</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Van Der Werf</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Brodt</span>
          <span class="cit-name-given-names">H-R</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Becker</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <abbr class="cit-jnl-abbrev">Identification of a novel coronavirus in patients with severe acute respiratory syndrome</abbr>. 
         <span class="cit-pub-date">2003</span>;
         <span class="cit-vol">348</span>(
         <span class="cit-issue">20</span>):
         <span class="cit-fpage">1967</span>–
         <span class="cit-lpage">76</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DIdentification%2Bof%2Ba%2Bnovel%2Bcoronavirus%2Bin%2Bpatients%2Bwith%2Bsevere%2Bacute%2Brespiratory%2Bsyndrome%26rft.volume%253D348%26rft.spage%253D1967%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">3.</span>
      <a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.3">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Walls</span>
          <span class="cit-name-given-names">AC</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Park</span>
          <span class="cit-name-given-names">Y-J</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Tortorici</span>
          <span class="cit-name-given-names">MA</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Wall</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">McGuire</span>
          <span class="cit-name-given-names">AT</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Veesler</span>
          <span class="cit-name-given-names">DJC</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</abbr>. 
         <span class="cit-pub-date">2020</span>.
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <span class="ref-label">4.</span>
      <a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text" id="ref-4">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.4">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Zaki</span>
          <span class="cit-name-given-names">AM</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Van Boheemen</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Bestebroer</span>
          <span class="cit-name-given-names">TM</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Osterhaus</span>
          <span class="cit-name-given-names">AD</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Fouchier</span>
          <span class="cit-name-given-names">RAJNEJoM</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</abbr>. 
         <span class="cit-pub-date">2012</span>;
         <span class="cit-vol">367</span>(
         <span class="cit-issue">19</span>):
         <span class="cit-fpage">1814</span>–
         <span class="cit-lpage">20</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DIsolation%2Bof%2Ba%2Bnovel%2Bcoronavirus%2Bfrom%2Ba%2Bman%2Bwith%2Bpneumonia%2Bin%2BSaudi%2BArabia%26rft.volume%253D367%26rft.spage%253D1814%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">5.</span>
      <a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.5">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Neher</span>
          <span class="cit-name-given-names">RA</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Dyrdak</span>
          <span class="cit-name-given-names">R</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Druelle</span>
          <span class="cit-name-given-names">V</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hodcroft</span>
          <span class="cit-name-given-names">EB</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Albert</span>
          <span class="cit-name-given-names">JJSMW</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Potential impact of seasonal forcing on a SARS-CoV-2 pandemic</abbr>. 
         <span class="cit-pub-date">2020</span>;
         <span class="cit-vol">150</span>(
         <span class="cit-issue">1112</span>).
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <span class="ref-label">6.</span>
      <a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.6">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Anand</span>
          <span class="cit-name-given-names">K</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Ziebuhr</span>
          <span class="cit-name-given-names">J</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Wadhwani</span>
          <span class="cit-name-given-names">P</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Mesters</span>
          <span class="cit-name-given-names">JR</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hilgenfeld</span>
          <span class="cit-name-given-names">RJS</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs</abbr>. 
         <span class="cit-pub-date">2003</span>;
         <span class="cit-vol">300</span>(
         <span class="cit-issue">5626</span>):
         <span class="cit-fpage">1763</span>–
         <span class="cit-lpage">7</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DCoronavirus%2Bmain%2Bproteinase%2B%25283CLpro%2529%2Bstructure%253A%2Bbasis%2Bfor%2Bdesign%2Bof%2Banti-SARS%2Bdrugs%26rft.volume%253D300%26rft.spage%253D1763%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">7.</span>
      <a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text" id="ref-7">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.7">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Hilgenfeld</span>
          <span class="cit-name-given-names">RJTFj</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design</abbr>. 
         <span class="cit-pub-date">2014</span>;
         <span class="cit-vol">281</span>(
         <span class="cit-issue">18</span>):
         <span class="cit-fpage">4085</span>–
         <span class="cit-lpage">96</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DFrom%2BSARS%2Bto%2BMERS%253A%2Bcrystallographic%2Bstudies%2Bon%2Bcoronaviral%2Bproteases%2Benable%2Bantiviral%2Bdrug%2Bdesign%26rft.volume%253D281%26rft.spage%253D4085%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">8.</span>
      <a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.8">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Ferenci</span>
          <span class="cit-name-given-names">P</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Scherzer</span>
          <span class="cit-name-given-names">TM</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Kerschner</span>
          <span class="cit-name-given-names">H</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Rutter</span>
          <span class="cit-name-given-names">K</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Beinhardt</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hofer</span>
          <span class="cit-name-given-names">H</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <abbr class="cit-jnl-abbrev">Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy</abbr>. 
         <span class="cit-pub-date">2008</span>;
         <span class="cit-vol">135</span>(
         <span class="cit-issue">5</span>):
         <span class="cit-fpage">1561</span>–
         <span class="cit-lpage">7</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DSilibinin%2Bis%2Ba%2Bpotent%2Bantiviral%2Bagent%2Bin%2Bpatients%2Bwith%2Bchronic%2Bhepatitis%2BC%2Bnot%2Bresponding%2Bto%2Bpegylated%2Binterferon%252Fribavirin%2Btherapy%26rft.volume%253D135%26rft.spage%253D1561%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">9.</span>
      <a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.9">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Chen</span>
          <span class="cit-name-given-names">L</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Li</span>
          <span class="cit-name-given-names">J</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Luo</span>
          <span class="cit-name-given-names">C</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Liu</span>
          <span class="cit-name-given-names">H</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Xu</span>
          <span class="cit-name-given-names">W</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Chen</span>
          <span class="cit-name-given-names">G</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <abbr class="cit-jnl-abbrev">Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features</abbr>. 
         <span class="cit-pub-date">2006</span>;
         <span class="cit-vol">14</span>(
         <span class="cit-issue">24</span>):
         <span class="cit-fpage">8295</span>–
         <span class="cit-lpage">306</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DBinding%2Binteraction%2Bof%2Bquercetin-3-%253F-galactoside%2Band%2Bits%2Bsynthetic%2Bderivatives%2Bwith%2BSARS-CoV%2B3CLpro%253A%2BStructure%253Factivity%2Brelationship%2Bstudies%2Breveal%2Bsalient%2Bpharmacophore%2Bfeatures%26rft.volume%253D14%26rft.spage%253D8295%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">10.</span>
      <a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text" id="ref-10">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.10">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Ginzberg</span>
          <span class="cit-name-given-names">I</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Tokuhisa</span>
          <span class="cit-name-given-names">JG</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Veilleux</span>
          <span class="cit-name-given-names">REJPR</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Potato steroidal glycoalkaloids: biosynthesis and genetic manipulation</abbr>. 
         <span class="cit-pub-date">2009</span>;
         <span class="cit-vol">52</span>(
         <span class="cit-issue">1</span>):
         <span class="cit-fpage">1</span>–
         <span class="cit-lpage">15</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DPotato%2Bsteroidal%2Bglycoalkaloids%253A%2Bbiosynthesis%2Band%2Bgenetic%2Bmanipulation%26rft.volume%253D52%26rft.spage%253D1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">11.</span>
      <a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text" id="ref-11">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.11">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Friedman</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">McDonald</span>
          <span class="cit-name-given-names">GM</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Filadelfi-Keszi</span>
          <span class="cit-name-given-names">MJCRiPS</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Potato glycoalkaloids: chemistry, analysis, safety, and plant physiology</abbr>. 
         <span class="cit-pub-date">1997</span>;
         <span class="cit-vol">16</span>(
         <span class="cit-issue">1</span>):
         <span class="cit-fpage">55</span>–
         <span class="cit-lpage">132</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DPotato%2Bglycoalkaloids%253A%2Bchemistry%252C%2Banalysis%252C%2Bsafety%252C%2Band%2Bplant%2Bphysiology%26rft.volume%253D16%26rft.spage%253D55%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">12.</span>
      <a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text" id="ref-12">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.12">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Thorne</span>
          <span class="cit-name-given-names">H</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Clarke</span>
          <span class="cit-name-given-names">G</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Skuce</span>
          <span class="cit-name-given-names">RJAr</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">The inactivation of herpes simplex virus by some Solanaceae glycoalkaloids</abbr>. 
         <span class="cit-pub-date">1985</span>;
         <span class="cit-vol">5</span>(
         <span class="cit-issue">6</span>):
         <span class="cit-fpage">335</span>–
         <span class="cit-lpage">43</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DThe%2Binactivation%2Bof%2Bherpes%2Bsimplex%2Bvirus%2Bby%2Bsome%2BSolanaceae%2Bglycoalkaloids%26rft.volume%253D5%26rft.spage%253D335%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">13.</span>
      <a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text" id="ref-13">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.13">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Banerjee</span>
          <span class="cit-name-given-names">P</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Eckert</span>
          <span class="cit-name-given-names">AO</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Schrey</span>
          <span class="cit-name-given-names">AK</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Preissner</span>
          <span class="cit-name-given-names">RJNar</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">ProTox-II: a webserver for the prediction of toxicity of chemicals</abbr>. 
         <span class="cit-pub-date">2018</span>;
         <span class="cit-vol">46</span>(
         <span class="cit-issue">W1</span>):
         <span class="cit-fpage">W257</span>–
         <span class="cit-lpage">W63</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DProTox-II%253A%2Ba%2Bwebserver%2Bfor%2Bthe%2Bprediction%2Bof%2Btoxicity%2Bof%2Bchemicals%26rft.volume%253D46%26rft.spage%253DW257%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">14.</span>
      <a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text" id="ref-14">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.14">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Esimone</span>
          <span class="cit-name-given-names">CO</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Eck</span>
          <span class="cit-name-given-names">G</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Nworu</span>
          <span class="cit-name-given-names">CS</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hoffmann</span>
          <span class="cit-name-given-names">D</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Überla</span>
          <span class="cit-name-given-names">K</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Proksch</span>
          <span class="cit-name-given-names">PJP</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Dammarenolic acid, a secodammarane triterpenoid from Aglaia sp. shows potent anti-retroviral activity in vitro</abbr>. 
         <span class="cit-pub-date">2010</span>;
         <span class="cit-vol">17</span>(
         <span class="cit-issue">7</span>):
         <span class="cit-fpage">540</span>–
         <span class="cit-lpage">7</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DDammarenolic%2Bacid%252C%2Ba%2Bsecodammarane%2Btriterpenoid%2Bfrom%2BAglaia%2Bsp.%2Bshows%2Bpotent%2Banti-retroviral%2Bactivity%2Bin%2Bvitro%26rft.volume%253D17%26rft.spage%253D540%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">15.</span>
      <a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text" id="ref-15">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.15">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Esimone</span>
          <span class="cit-name-given-names">C</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Eck</span>
          <span class="cit-name-given-names">G</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Duong</span>
          <span class="cit-name-given-names">T</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Überla</span>
          <span class="cit-name-given-names">K</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Proksch</span>
          <span class="cit-name-given-names">P</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Grunwald</span>
          <span class="cit-name-given-names">TJDP-AIJoPS</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Potential anti-respiratory syncytial virus lead compounds from Aglaia species</abbr>. 
         <span class="cit-pub-date">2008</span>;
         <span class="cit-vol">63</span>(
         <span class="cit-issue">10</span>):
         <span class="cit-fpage">768</span>–
         <span class="cit-lpage">73</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DPotential%2Banti-respiratory%2Bsyncytial%2Bvirus%2Blead%2Bcompounds%2Bfrom%2BAglaia%2Bspecies%26rft.volume%253D63%26rft.spage%253D768%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">16.</span>
      <a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text" id="ref-16">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.16">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Liu</span>
          <span class="cit-name-given-names">C-H</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Jassey</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hsu</span>
          <span class="cit-name-given-names">H-Y</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Lin</span>
          <span class="cit-name-given-names">L-TJM</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Antiviral Activities of Silymarin and Derivatives</abbr>. 
         <span class="cit-pub-date">2019</span>;
         <span class="cit-vol">24</span>(
         <span class="cit-issue">8</span>):
         <span class="cit-fpage">1552</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DAntiviral%2BActivities%2Bof%2BSilymarin%2Band%2BDerivatives%26rft.volume%253D24%26rft.spage%253D1552%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">17.</span>
      <a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text" id="ref-17">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.17">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Polyak</span>
          <span class="cit-name-given-names">SJ</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Ferenci</span>
          <span class="cit-name-given-names">P</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Pawlotsky</span>
          <span class="cit-name-given-names">JMJH</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection</abbr>. 
         <span class="cit-pub-date">2013</span>;
         <span class="cit-vol">57</span>(
         <span class="cit-issue">3</span>):
         <span class="cit-fpage">1262</span>–
         <span class="cit-lpage">71</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DHepatoprotective%2Band%2Bantiviral%2Bfunctions%2Bof%2Bsilymarin%2Bcomponents%2Bin%2Bhepatitis%2BC%2Bvirus%2Binfection%26rft.volume%253D57%26rft.spage%253D1262%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">18.</span>
      <a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text" id="ref-18">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.18">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Wagoner</span>
          <span class="cit-name-given-names">J</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Negash</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Kane</span>
          <span class="cit-name-given-names">OJ</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Martinez</span>
          <span class="cit-name-given-names">LE</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Nahmias</span>
          <span class="cit-name-given-names">Y</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Bourne</span>
          <span class="cit-name-given-names">N</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <abbr class="cit-jnl-abbrev">Multiple effects of silymarin on the hepatitis C virus lifecycle</abbr>. 
         <span class="cit-pub-date">2010</span>;
         <span class="cit-vol">51</span>(
         <span class="cit-issue">6</span>):
         <span class="cit-fpage">1912</span>–
         <span class="cit-lpage">21</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DMultiple%2Beffects%2Bof%2Bsilymarin%2Bon%2Bthe%2Bhepatitis%2BC%2Bvirus%2Blifecycle%26rft.volume%253D51%26rft.spage%253D1912%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">19.</span>
      <a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text" id="ref-19">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.19">
       <div class="cit-metadata">
        <cite>
         <span class="cit-pub-id cit-pub-id-doi">
          <span class="cit-pub-id-scheme-doi">doi:</span>10.2210/pdb6LU7/pdb
         </span>.
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <span class="ref-label">20.</span>
      <a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text" id="ref-20">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.20">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Biovia</span>
          <span class="cit-name-given-names">DSJSD</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">Discovery Studio Modeling Environment Release 2017, Dassault Systemes</abbr>. 
         <span class="cit-pub-date">2016</span>.
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <span class="ref-label">21.</span>
      <a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text" id="ref-21">↵</a>
      <div class="cit ref-cit ref-book" id="cit-2020.03.31.017657v1.21">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Dallakyan</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Olson</span>
          <span class="cit-name-given-names">AJ</span>
         </span>. 
         <span class="cit-chapter-title">Small-molecule library screening by docking with PyRx</span>. 
         <span class="cit-source">Chemical biology</span>: 
         <span class="cit-publ-name">Springer</span>; 
         <span class="cit-pub-date">2015</span>.p. 
         <span class="cit-fpage">243</span>–
         <span class="cit-lpage">50</span>.
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <span class="ref-label">22.</span>
      <a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text" id="ref-22">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.22">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Daina</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Michielin</span>
          <span class="cit-name-given-names">O</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Zoete</span>
          <span class="cit-name-given-names">VJSr</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules</abbr>. 
         <span class="cit-pub-date">2017</span>;
         <span class="cit-vol">7</span>:
         <span class="cit-fpage">42717</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DSwissADME%253A%2Ba%2Bfree%2Bweb%2Btool%2Bto%2Bevaluate%2Bpharmacokinetics%252C%2Bdrug-likeness%2Band%2Bmedicinal%2Bchemistry%2Bfriendliness%2Bof%2Bsmall%2Bmolecules%26rft.volume%253D7%26rft.spage%253D42717%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">23.</span>
      <a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23. in text" id="ref-23">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.23">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Jarrahpour</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Motamedifar</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Zarei</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Youssoufi</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Mimouni</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Chohan</span>
          <span class="cit-name-given-names">Z</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <abbr class="cit-jnl-abbrev">Petra, osiris, and molinspiration together as a guide in drug design: predictions and correlation structure/antibacterial activity relationships of new N-Sulfonyl monocyclic β-lactams</abbr>. 
         <span class="cit-pub-date">2010</span>;
         <span class="cit-vol">185</span>(
         <span class="cit-issue">2</span>):
         <span class="cit-fpage">491</span>–
         <span class="cit-lpage">7</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DPetra%252C%2Bosiris%252C%2Band%2Bmolinspiration%2Btogether%2Bas%2Ba%2Bguide%2Bin%2Bdrug%2Bdesign%253A%2Bpredictions%2Band%2Bcorrelation%2Bstructure%252Fantibacterial%2Bactivity%2Brelationships%2Bof%2Bnew%2BN-Sulfonyl%2Bmonocyclic%2B%253F-lactams%26rft.volume%253D185%26rft.spage%253D491%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">24.</span>
      <a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text" id="ref-24">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.31.017657v1.24">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Drwal</span>
          <span class="cit-name-given-names">MN</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Banerjee</span>
          <span class="cit-name-given-names">P</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Dunkel</span>
          <span class="cit-name-given-names">M</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Wettig</span>
          <span class="cit-name-given-names">MR</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Preissner</span>
          <span class="cit-name-given-names">RJNar</span>
         </span>. 
         <abbr class="cit-jnl-abbrev">ProTox: a web server for the in silico prediction of rodent oral toxicity</abbr>. 
         <span class="cit-pub-date">2014</span>;
         <span class="cit-vol">42</span>(
         <span class="cit-issue">W1</span>):
         <span class="cit-fpage">W53</span>–
         <span class="cit-lpage">W8</span>.
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DProTox%253A%2Ba%2Bweb%2Bserver%2Bfor%2Bthe%2Bin%2Bsilico%2Bprediction%2Bof%2Brodent%2Boral%2Btoxicity%26rft.volume%253D42%26rft.spage%253DW53%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
       </div>
      </div>
     </li>
    </ol>
   </div>
   <span class="highwire-journal-article-marker-end"/>
  </div>
 </body>
</html>
